Mark S. Longtine

Mallinckrodt (United States)United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

36h-index13.8kcitations81works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

Fungal and yeast genetics research(31), Pregnancy and preeclampsia studies(15), Fermentation and Sensory Analysis(12), Radiopharmaceutical Chemistry and Applications(11), Biofuel production and bioconversion(8)

Publications81 total

Cancer Biotherapy and Radiopharmaceuticals·2022· 6 citedOpen Access
Biodistribution of 89Zr-ofatumumab and 177Lu-ofatumumab as a Theranostic Pair for Lymphoma
2021· 1 cited
Journal of Nuclear Medicine·2021· 12 citedOpen Access
UNC Libraries·2020Open Access
Frontiers in Oncology·2020· 23 citedOpen Access
Comparative Biodistribution of 89Zr-ofatumumab and 225Ac-ofatumumab for Lymphoma Radioimmunotherapy
2020· 1 cited
Targeting of PD-L1 in mouse xenograft tumors by 89Zr-atezolizumab is specific but strongly mass-dependent
2019
Radioresistant Rag2-IL2rg (R2G2) mice demonstrate position-dependent bioluminescent tumor signal and increased lethality compared to severe combined immunodeficient (SCID) mice in a disseminated lymphoma model.
2019
page 1 of 5Next →

Frequent Co-authors

D. Michael Nelson(16), John R. Pringle(14), Judith Berman(7), Baosheng Chen(7), Amos Mckenzie(5), B. Chen(5), Shinichiro Enomoto(5), Nirav G. Shah(4), Achim Wach(4), Peter Philippsen(4), Erfei Bi(4), Douglas J. DeMarini(3), Methodius G. Tuuli(3), Anthony Odibo(3), Yan Zhong(3), Stacey L. Finstad(3), Arndt Brachat(2), Jürg Bähler(2), Alexander B. Steever(2), Neil Adames(2)